ChinaByteDance’s AI drug unit is worth about $1.5 billion.

Huawei, OpenAI, Anthropic and Nvidia are also moving into drug discovery.

Anew Labs, spun out in June, raised $290 million in its first round three months later.

Huawei’s pharma chief Fan Jie says the company will not make drugs, only supply AI to drugmakers.

Isomorphic Labs’ first AI-designed cancer drug is about to enter human trials.

How each outlet framed it
TMTPost
reframes AI drug discovery against the 5,000-year sampling problem, citing Ciba-Geigy's 3×10^62 compound count

Sources: TMTPost